Abstract
The latest addition to the serotonin (5-HT) receptor family is the 5-HT7 receptor (5-HT7R). This receptor has gained interest as a drug target due to its involvement in various disorders such as depression or schizophrenia. There is currently no clinically validated positron emission tomography (PET) tracer for the 5-HT7R available. But, the (arylpiperazinyl-butyl)oxindole scaffold provides a promising lead structure for this purpose. Here, we synthesized 12 (arylpiperazinyl-butyl)oxindole derivatives and in vitro affinity screening identified two structures with suitable affinity and selectivity to be radiolabeled and tested as 5-HT7R selective PET tracers. Next, the radiolabeled products [18F]ENL09 and [18F]ENL10 were evaluated as PET tracers in rats. Both tracers were found to be P-gp substrates, but after P-gp inhibition the brain uptake showed a regional distribution in line with the known 5-HT7R distribution. The [18F]ENL10 brain binding was displaceable with a 5-HT7R selective ligand, whereas [18F]ENL09 was not. We find that [18F]ENL10 is a promising 5-HT7R selective PET tracer candidate that should be investigated in higher species.
Original language | English |
---|---|
Journal | ACS Chemical Neuroscience |
Volume | 10 |
Issue number | 9 |
Pages (from-to) | 3961-3968 |
ISSN | 1948-7193 |
DOIs | |
Publication status | Published - 18. Sept 2019 |
Externally published | Yes |
Keywords
- Animals
- Brain/diagnostic imaging
- Drug Development/methods
- Drug Evaluation, Preclinical/methods
- Female
- Fluorine Radioisotopes/administration & dosage
- Injections, Intravenous
- Positron-Emission Tomography/methods
- Rats
- Rats, Long-Evans
- Receptors, Serotonin/metabolism
- Serotonin Antagonists/administration & dosage